SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-20-000798
Filing Date
2020-01-10
Accepted
2020-01-10 17:24:29
Documents
5
Period of Report
2019-10-31
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K f8k011020a1_aytubioscience.htm 8-K/A 32403
2 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS OF THE ABBREVIATED FINANCIAL f8k011020a1ex23-1_aytubio.htm EX-23.1 2785
3 AUDITED HISTORICAL ABBREVIATED FINANCIAL STATEMENTS FOR THE PEDIATRICS PRODUCT P f8k011020a1ex99-1_aytubio.htm EX-99.1 200409
4 UNAUDITED HISTORICAL ABBREVIATED FINANCIAL STATEMENTS FOR THE PEDIATRICS PRODUCT f8k011020a1ex99-2_aytubio.htm EX-99.2 116964
5 UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET AS OF JUNE 30, 2019 AND STA f8k011020a1ex99-3_aytubio.htm EX-99.3 212696
  Complete submission text file 0001213900-20-000798.txt   566593
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 001-38247 | Film No.: 20522025
SIC: 2834 Pharmaceutical Preparations